Gene expression signature of dmba-induced hamster buccal pouch carcinomas: Modulation by chlorophyllin and ellagic acid

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Priyadarsini, Ramamurthi Vidhya ^a   Kumar, Neeraj ^b   Khan, Imran ^b   Thiyagarajan, Paranthaman ^a   Kondaiah, Paturu ^b   Nagini, Siddavaram ^a  

^a ANNAMALAI UNIVERSITY   (India)

^b INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROPHYLL; CYCLIN D1; DIMETHYLBENZ[A]ANTHRACENE; DNA; ELLAGIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRIX METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; 7,12 DIMETHYLBENZ[A]ANTHRACENE; ANTINEOPLASTIC AGENT; CHLOROPHYLLIDE;

ANIMAL EXPERIMENT; ARTICLE; BUCCAL POUCH CARCINOMA; CANCER PREVENTION; CARCINOGENESIS; CHEEK POUCH; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DIET SUPPLEMENTATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; HAMSTER; HISTOPATHOLOGY; MALE; MALIGNANT TRANSFORMATION; MICROARRAY ANALYSIS; MODULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; ANIMAL; CELL TRANSFORMATION; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; MOUTH MUCOSA; MOUTH TUMOR; PATHOLOGY; SQUAMOUS CELL CARCINOMA; SYRIAN HAMSTER; TUMOR VOLUME;

ANIMALIA; CRICETINAE; VITACEAE;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; ANTICARCINOGENIC AGENTS; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; CHLOROPHYLLIDES; CRICETINAE; DIETARY SUPPLEMENTS; ELLAGIC ACID; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; MALE; MESOCRICETUS; MOUTH MUCOSA; MOUTH NEOPLASMS; TRANSCRIPTION, GENETIC; TUMOR BURDEN;

EID: 84859228218     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034628     Document Type: Article

References (49)

1. Vidya Priyadarsini R, Nagini S, (2012) Cancer chemoprevention by dietary phytochemicals: promises and pitfalls. Curr Pharm Biotechnol 13: 125-136.
2. Dashwood R, (1997) Chlorophylls as anticarcinogens. Int J Oncol 10: 721-727.
3. Osowski A, Pietrzak M, Wieczorek Z, Wieczorek J, (2010) Natural compounds in the human diet and their ability to bind mutagens prevents DNA-mutagen intercalation. J Toxicol Environ Health A 73: 1141-1149.
4. Teel RW, (1986) Ellagic acid binding to DNA as a possible mechanism for its antimutagenic and anticarcinogenic action. Cancer Lett 30: 329-336.
5. Dashwood RH, Negishi T, Hayatsu H, Breinholt V, Hendricks JD, (1998) Chemopreventive properties of chlorophylls towards aflatoxin B1: a review of the antimutagenicity and anticarcinogenicity data in rainbow trout. Mutat Res 399: 245-253.
6. Chiu LC, Kong CK, Ooi VE, (2005) The chlorophyllin-induced cell cycle arrest and apoptosis in human breast cancer MCF-7 cells is associated with ERK deactivation and cyclin D1 depletion. Int J Mol Med 16: 735-740.
7. Carter O, Bailey GS, Dashwood RH, (2004) The dietary phytochemical chlorophyllin alters E-cadherin and beta-catenin expression in human colon cancer cells. J Nutr 34: 3441S-344S.
8. Chiu LC, Kong CK, Ooi VE, (2003) Antiproliferative effect of chlorophyllin derived from a traditional Chinese medicine Bombyx mori excreta on human breast cancer MCF-7 cells. Int J Oncol 23: 729-735.
9. Egner PA, Wang JB, Zhu YR, Zhang BC, Wu Y, (2001) Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer. Proc Natl Acad Sci U S A 98: 14601-14606.
10. Dixit R, Gold B, (1986) Inhibition of N-methyl-N-nitrosourea-induced mutagenicity and DNA methylation by ellagic acid. Proc Natl Acad Sci USA 83: 8039-8043.
11. Mukhtar H, Das M, Bickers DR, (1986) Inhibition of 3-methylcholanthrene-induced skin tumongenicity in BALB/C mice by chronic oral feeding of trace amounts of ellagic acid in drinking water. Cancer Res 46: 2262-2265.
12. Mandal S, Ahuja A, Shivapurkar NM, Cheng SJ, Groopman JD, (1987) Inhibition of aflatoxin B1 mutagenesis in Salmonella typhimurium and DNA damage in cultured rat and human tracheobronchial tissues by ellagic acid. Carcinogenesis 8: 1651-1656.
13. Lesca P, (1983) Protective effects of ellagic acid and other plant phenols on benzo[a]pyrene-induced neoplasia in mice. Carcinogenesis 4: 1651-1653.
14. Gonzalez-Sarrias A, Espin JC, Tomas-Barberan FA, Garcia-Conesa MT, (2009) Gene expression, cell cycle arrest and MAPK signalling regulation in Caco-2 cells exposed to ellagic acid and its metabolites, urolithins. Mol Nutr Food Res 2009: 686-698.
15. Hagiwara Y, Kasukabe T, Kaneko Y, Niitsu N, Okabe-Kado J, (2010) Ellagic acid, a natural polyphenolic compound, induces apoptosis and potentiates retinoic acid-induced differentiation of human leukemia HL-60 cells. Int J Hematol 92: 136-143.
16. Umesalma S, Sudhandiran G, (2010) Differential inhibitory effects of the polyphenol ellagic acid on inflammatory mediators NF-kappaB, iNOS, COX-2, TNF-alpha, and IL-6 in 1,2-dimethylhydrazine-induced rat colon carcinogenesis. Basic Clin Pharmacol Toxicol 107: 650-655.
17. Aiyer HS, Gupta RC, (2010) Berries and ellagic acid prevent estrogen-induced mammary tumorigenesis by modulating enzymes of estrogen metabolism. Cancer Prev Res 3: 727-737.
18. Tanaka T, Kojima T, Kawamori T, Wang A, Suzui M, (1993) Inhibition of 4-nitroquinoline-1-oxide-induced rat tongue carcinogenesis by the naturally occurring plant phenolics caffeic, ellagic, chlorogenic and ferulic acids. Carcinogenesis 14: 1321-1325.
19. Nagini S, (2009) Of humans and hamsters: The hamster buccal pouch carcinogenesis model as a paradigm for oral oncogenesis and chemoprevention. Anticancer Agents Med Chem 9: 843-852.
20. Wang R, Dashwood WM, Bailey GS, Williams DE, Dashwood RH, (2006) Tumors from rats given 1,2-dimethylhydrazine plus chlorophyllin or indole-3-carbinol contain transcriptional changes in beta-catenin that are independent of beta-catenin mutation status. Mutat Res 601: 11-18.
21. Simonich MT, Mc Quistan T, Jubert C, Pereira C, Hendricks JD, (2008) Low-dose dietary chlorophyll inhibits multi-organ carcinogenesis in the rainbow trout. Food Chem Toxicol 46: 1014-1024.
22. Kelly RJ, Morris JC, (2010) Transforming growth factor-beta: a target for cancer therapy. J Immunotoxicol 7: 15-26.
23. Hawinkels LJ, Ten Dijke P, (2011) Exploring anti-TGF-β therapies in cancer and fibrosis. Growth Factors 29: 140-152.
24. Santibañez JF, Quintanilla M, Bernabeu C, (2011) TGF-β/TGF-β receptor system and its role in physiological and pathological conditions. Clin Sci 121: 233-251.
25. Meulmeester E, Ten Dijke P, (2011) The dynamic roles of TGF-β in cancer. J Pathol 223: 205-218.
26. Baud V, Karin M, (2009) Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls. Nat Rev Drug Discov 8: 33-40.
27. Luqman S, Pezzuto JM, (2010) NFkappaB: a promising target for natural products in cancer chemoprevention. Phytother Res 24: 949-963.
28. Chaturvedi MM, Sung B, Yadav VR, Kannappan R, Aggarwal BB, (2011) NF-κB addiction and its role in cancer: 'one size does not fit all'. Oncogene 30: 1615-1630.
29. Gupta SC, Kim JH, Prasad S, Aggarwal BB, (2010) Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev 29: 405-434.
30. Witzel II, Koh LF, Perkins ND, (2010) Regulation of cyclin D1 gene expression. Biochem Soc Trans 38: 217-222.
31. Hsieh HL, Wang HH, Wu WB, Chu PJ, Yang CM, (2010) Transforming growth factor-β1 induces matrix metalloproteinase-9 and cell migration in astrocytes: roles of ROS-dependent ERK- and JNK-NF-κB pathways. J Neuroinflammation 7: 88.
32. Tobar N, Villar V, Santibanez JF, (2010) ROS-NFkappaB mediates TGF-beta1-induced expression of urokinase-type plasminogen activator, matrix metalloproteinase-9 and cell invasion. Mol Cell Biochem 340: 195-202.
33. Beltran E, Fresquet V, Martinez-Useros J, Richter-Larrea JA, Sagardoy A, et al. (2011) A cyclin-D1 interaction with BAX underlies its oncogenic role and potential as a therapeutic target in mantle cell lymphoma. Proc Natl Acad Sci USA 108: 12461-12466.
34. Musgrove EA, Caldon CE, Barraclough J, Stone A, Sutherland RL, (2011) Cyclin D as a therapeutic target in cancer. Nat Rev Cancer 11: 558-572.
35. Elahi M, Rakhshan V, Ghasemian NT, Moshref M, (2012) Prognostic value of transforming growth factor beta 1 [TGF-β1] and matrix metalloproteinase 9 [MMP-9] in oral squamous cell carcinoma. Biomarkers 17: 21-27.
36. Binker MG, Binker-Cosen AA, Gaisano HY, de Cosen RH, Cosen-Binker LI, (2011) TGF-β1 increases invasiveness of SW1990 cells through Rac1/ROS/NF-κB/IL-6/MMP-2. Biochem Biophys Res Commun 405: 140-145.
37. Huber MA, Azoitei N, Baumann B, Grünert S, Sommer A, et al. (2004) NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Invest 114: 569-581.
38. Fujiwara Y, Furukawa K, Haruki K, Shimada Y, Iida T, et al. (2011) Nafamostat mesilate can prevent adhesion, invasion and peritoneal dissemination of pancreatic cancer through nuclear factor kappa-B inhibition. J Hepatobiliary Pancreat Sci 18: 731-739.
39. Hua H, Li M, Luo T, Yin Y, Jiang Y, (2011) Matrix metalloproteinases in tumorigenesis: an evolving paradigm. Cell Mol Life Sci 68: 3853-3868.
40. Gialeli C, Theocharis AD, Karamanos NK, (2011) Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J 278: 16-27.
41. Yang K, Zhang G, Mei J, Chen D, Wu M, (2010) Screening and analysis of pathogenic genes during DMBA induced buccal mucosa carcinogenesis in golden hamsters. Oncol Rep 23: 1619-1624.
42. Anitha P, Vidya Priyadarsini R, Kavitha K, Thiyagarajan P, Nagini S, (2011) Ellagic acid co-ordinately attenuates Wnt/β-catenin and NF-κB signaling pathways to induce intrinsic apoptosis in an animal model of oral oncogenesis. Eur J Nutr In press.
43. Gradecka-Meesters D, Palus J, Prochazka G, Segerback D, Dziubałtowska E, et al. (2011) Assessment of the protective effects of selected dietary anticarcinogens against DNA damage and cytogenetic effects induced by benzo[a]pyrene in C57BL/6J mice. Food Chem Toxicol 49: 1674-1683.
44. Lagerqvist A, Hakansson D, Frank H, Seidel A, Jenssen D, (2011) Structural requirements for mutation formation from polycyclic aromatic hydrocarbon dihydrodiol epoxides in their interaction with food chemopreventive compounds. Food Chem Toxicol 49: 879-886.
45. Vidya Priyadarsini R, Vinothini G, Senthil Murugan R, Manikandan P, Nagini S, (2011) The flavonoid quercetin modulates the hallmark capabilities of hamster buccal pouch tumours. Nutr Cancer 63: 218-226.
46. Madrigal-Bujaidar E, Velazquez-Guadarrama N, Diaz-Barriga S, (1997) Inhibitory effect of chlorophyllin on the frequency of sister chromatid exchanges produced by benzo[a]pyrene in vivo. Mutat Res 388: 79-83.
47. Singletary K, Liao CH, (1989) Ellagic acid effects on the carcinogenicity, DNA-binding and metabolism of 7,12-dimethylbenz(a)anthracene (DMBA). In Vivo 3: 173-175.
48. Nagini S, Vidjaya Letchoumy P, Thangavelu A, Ramachandran CR, (2009) Of humans and hamsters: A comparative evaluation of carcinogen activation, DNA damage, cell proliferation, apoptosis, invasion, and angiogenesis in oral cancer patients and hamster buccal pouch carcinomas. Oral Oncol 45: e31-37.
49. Yee JC, Wlaschin KF, Chuah SH, Nissom PM, Hu WS, (2008) Quality assessment of cross-species hybridization of CHO transcriptome on a mouse DNA oligo microarray. Biotechnol Bioeng 101: 1359-1365.